Low Hospital Volume Increases Revision Rate and Mortality Following Revision Total Hip Arthroplasty: An Analysis of 17,773 Cases |
| |
Authors: | Elke Jeschke Thorsten Gehrke Christian Günster Karl-Dieter Heller Hanna Leicht Jürgen Malzahn Fritz Uwe Niethard Peter Schräder Josef Zacher Andreas M. Halder |
| |
Affiliation: | 1. Research Institute of the Local Health Care Funds, Berlin, Germany;2. Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany;3. Department of Orthopaedic Surgery, Herzogin Elisabeth Hospital, Braunschweig, Germany;4. Federal Association of the Local Health Care Funds, Berlin, Germany;5. German Society of Orthopedics and Orthopedic Surgery, Berlin, Germany;6. Department of Orthopaedic Surgery, Kreisklinik Jugenheim, Jugenheim, Germany;7. Department of Orthopaedic Surgery, Helios Kliniken GmbH, Berlin, Germany;8. Department of Orthopaedic Surgery, Sana Kliniken Sommerfeld, Sommerfeld, Germany |
| |
Abstract: | BackgroundWith the number of primary total hip arthroplasty (THA), the amount of revision THA (R-THA) increases. R-THA is a complex procedure requiring special instruments, implants, and surgical skills. Therefore it is likely that hospitals performing a higher number of R-THAs have more experience with this type of surgery and therefore fewer complications. The purpose of this study was to evaluate the relationship between hospital volume and risk of postoperative complications following R-THA.MethodsUsing nationwide healthcare insurance data for inpatient hospital treatment, 17,773 aseptic R-THAs in 16,376 patients treated between January 2014 and December 2016 were included. Outcomes were 90-day mortality, 1-year revision procedures, and in-house adverse events. The effect of hospital volume on outcome was analyzed by means of multivariate logistic regression. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.ResultsHospital volume had a significant effect on 90-day mortality (≤12 cases per year: OR 2.13, CI 1.53-2.96; 13-24: OR 1.79, CI 1.29-2.50; 25-52: OR 1.53, CI 1.11-2.10; ≥53: reference) and 1-year revision procedures (≤12: OR 1.26, CI 1.09-1.47; 13-24: OR 1.18, CI 1.02-1.37; 25-52: OR 1.03, CI 0.90-1.19; ≥53: reference). There was no significant effect on risk-adjusted major in-house adverse events.ConclusionWe found evidence of higher risk for revision surgery and mortality in hospitals with fewer than 25 and 53 R-THA per year, respectively. To improve patient care, complex elective procedures like R-THA which require experience and a specific logistic background should be performed in specialized centers. |
| |
Keywords: | Reprint requests: Andreas M. Halder, MD, Klinik für Endoprothetik, D-16766 Sommerfeld Kremmen, Waldhausstrasse 44, Germany. volume-outcome revision total hip arthroplasty mortality revision rate arthroplasty complications |
本文献已被 ScienceDirect 等数据库收录! |
|